<- Go Home
NS Wind Down Co., Inc.
NS Wind Down Co., Inc. develops, manufactures, and sells technology for scientific and clinical information in the fields of genomics and proteomics in the Americas, Europe, the Middle East, and the Asia Pacific. The company offers nCounter Analysis System, an automated, multi-application, digital detection, and counting system. It provides nCounter Pro and FLEX systems that include Prep Station, an automated liquid handling component that processes and prepares samples for data collection; and nCounter Digital Analyzer, which collects data from samples by taking images of the immobilized fluorescent reporters in the sample cartridge and processing the data into output files. The company also offers nCounter SPRINT Profiler, an instrument that provides liquid handling steps and the digital analysis; and nSolver Analysis Software, a data analysis program that enables researchers to check, normalize, and analyze their data. In addition, it provides custom CodeSets; and panels with oncology, immunology and infectious disease, and neuroscience applications. Further, the company offers Master Kits, cartridges, ancillary reagents, tips and reagent plates to setup and process samples in instruments; and Prosigna in vitro diagnostic kits. The company is also developing GeoMx DSP system to enable the field of spatial biology. It has collaborations with Lam Research Corporation and Parker Institute for Cancer Immunotherapy, Stanford Medicine, Acrobat Genomics, and Illumina Accelerator. The company was formerly known as NanoString Technologies, Inc. and changed its name to NS Wind Down Co., Inc. in May 2024. NS Wind Down Co., Inc. was incorporated in 2003 and is headquartered in Seattle, Washington.
Market Cap
MXN 3.5M
Volume
4.2K
Cash and Equivalents
MXN 93.8M
EBITDA
-MXN 148.5M
Tax Rate Collected
N/A
Tax Rate Ratio
N/A
Gross Profit
MXN 58.0M
Profit Margin
35.72%
52 Week High
MXN 5.18
52 Week Low
MXN 0.04
Dividend
N/A
Price / Book Value
-0.07
Price / Earnings
-0.02
Price / Tangible Book Value
-0.07
Enterprise Value
MXN 154.1M
Enterprise Value / EBITDA
-1.08
Operating Income
-MXN 162.6M
Return on Equity
1028.56%
Return on Assets
-30.87
Cash and Short Term Investments
MXN 97.1M
Debt
MXN 247.7M
Equity
-MXN 50.6M
Revenue
MXN 162.5M
Unlevered FCF
-MXN 78.3M
Sector
Life Sciences Tools and Services
Category
N/A
Hedge Funds that own this stock
PREMIUM
Upgrade to Yellowbrick Premium to unlock the Professional Funds that own this company (and many other perks).
Upgrade to Yellowbrick PremiumYellowbrick Portfolios that own this stock
PREMIUM
Upgrade to Yellowbrick Premium to unlock the Yellowbrick portfolios that own this company (and many other perks).
Upgrade to Yellowbrick Premium